Efectividad de la reconstrucción de la oreja con cartílago costal en el tratamiento de microtias / Effectiveness of Auricle Reconstruction with Costal Cartilage for the Treatment of Microtias

Introducción: La reconstrucción de la oreja en la actualidad es un problema difícil de solucionar. Se han propuesto varias técnicas quirúrgicas y solo las que se basan en el uso de cartílago costal autólogo son las que se aceptan a nivel mundial. Objetivo: Evaluar la efectividad de la técnica de reconstrucción del pabellón auricular descrita por Burt Brent. Métodos: Se realizó un estudio cuantitativo con diseño descriptivo de corte transversal con 41 pacientes que presentaron microtia congénita o perdida adquirida de la oreja; a quienes se les realizó reconstrucción auricular con cartílago costal autólogo tratados en el Hospital "William Soler", el Centro de Investigaciones Médico-Quirúrgica y Clínica Central "Cira García" en el Servicio de Cirugía Plástica desde 1994 hasta 2019. Se describió y se documentó la técnica empleada descrita por Burt Brent. Se utilizó una escala de 10 puntos que se basó en la anatomía auricular normal para la valoración de los resultados. Resultados: Se encontraron 32 pacientes portadores de microtia congénitas (78,04 %) y 9 pérdidas traumáticas (21,95 %), predominó el sexo femenino (56,09 %). La incidencia fue mayor en el lado derecho (68,75 %) en pacientes con microtia congénita. En el 95 % de los casos se alcanzaron resultados favorables y satisfactorios. Conclusiones: La reconstrucción del pabellón auricular requiere el empleo de un fragmento de cartílago costal de suficiente tamaño, forma y proyección. La clave consiste en esculpir un marco cartilaginoso de la oreja y mantener estos detalles a través de la piel lo más semejante a la oreja normal. Para un resultado satisfactorio se requiere una alta especialización.

Introduction: Auricle reconstruction is, nowadays, a difficult problem to solve. Several surgical techniques have been proposed and only those based on the use of autologous costal cartilage are accepted worldwide. Objective: To evaluate the effectiveness of the auricle reconstruction technique described by Burt Brent. Methods: A quantitative study with a cross-sectional descriptive design was carried out with 41 patients who presented congenital microtia or acquired loss of the ear and who were performed auricle reconstruction with autologous costal cartilage in the plastic surgery service at Hospital "William Soler", Centro de Investigaciones Médico-Quirúrgicas and Clínica Central "Cira García", from 1994 to 2019. The used technique described by Burt Brent was, in turn, described and documented. A 10-point scale based on the normal atrial anatomy was used to assess the outcomes. Results: Thirty-two patients with congenital microtia (78.04 %) and nine traumatic losses (21.95 %) were found, with a predominance of the female sex (56.09 %). The incidence was higher on the right side (68.75 %) in patients with congenital microtia. Favorable and satisfactory outcomes were achieved in 95 % of cases. Conclusions: Auricle reconstruction requires the use of a costal cartilage piece of enough size, shape and projection. The key is to sculpt a cartilaginous framework of the ear and to maintain these details through the skin as close as possible to the normal ear. A high level of specialization is required for a satisfactory outcome.

Guía para el diagnóstico, estudio y tratamiento de la infección urinaria: actualización 2022 / Clinical practice guideline for the diagnosis and management of urinary tract infections: 2022 update

En 2015 se publicaron en Archivos Argentinos de Pediatría las "Nuevas recomendaciones frente a las actuales controversias en infección urinaria". Dado que en estos años surgieron evidencias con respecto al diagnóstico, la forma de estudio y el tratamiento de la infección urinaria, el Comité de Nefrología Pediátrica de la Sociedad Argentina de Pediatría decidió actualizar dichas recomendaciones. El objetivo principal es brindar al pediatra las herramientas para realizar un correcto diagnóstico, definir el tratamiento más adecuado, seleccionar a los pacientes que se beneficiarán con la profilaxis antibiótica y decidir cuáles serán los estudios de imágenes necesarios, para evitar intervenciones costosas e invasivas. En estas guías se incluyen, además, los lineamientos para el manejo de niños con infecciones urinarias asociadas a situaciones especiales como la disfunción vesicointestinal, el recién nacido, los portadores de vejiga neurogénica, los receptores de trasplante renal y las infecciones urinarias micóticas.

In 2015, the "New recommendations regarding the current controversies in urinary infection" were published in the Archivos Argentinos de Pediatría. Given the fact that in these past years, new evidence has emerged regarding the diagnosis and treatment of urinary infection, the Pediatric Nephrology Committee of Sociedad Argentina de Pediatría has decided to update these recommendations. The main goal is to provide the pediatrician with the necessary tools to make a correct diagnosis, define the most appropriate treatment, select the patients who will benefit from antibiotic prophylaxis, and decide which imaging studies will be necessary, avoiding costly and invasive interventions. These guidelines also include the management of children with urinary tract infections associated with special situations such as: bladder bowel dysfunction, the newborn, children with neurogenic bladder, kidney transplant patients and fungal urinary tract infections.

Prevalencia de compromiso renal en pacientes pediátricos internados con enfermedad por coronavirus 2019: estudio multicéntrico / Prevalence of renal involvement among pediatric patients hospitalized due to coronavirus disease 2019: A multicenter study

Introducción. El compromiso renal (CR) en niñosinternados con enfermedad por coronavirus2019 (COVID-19, por su sigla en inglés) varía entre el 1,2 % y el 44 %. Dado que existe limitada información local, el objetivo primario de este estudio fue estimar la prevalencia de CR en nuestro medio. Población y métodos. Estudio transversalrealizado en 13 centros de Argentina entre marzo y diciembre de 2020. Se incluyeron pacientes internados con COVID-19, de 1 mes a 18 años y que tuvieran al menos una determinación de creatinina sérica y/o de orina completa.Se excluyeron aquellos con enfermedad renal conocida. Se consideró CR la presencia de lesión renal aguda (LRA), proteinuria, hematuria, leucocituria y/o hipertensión arterial (HTA). Resultados. De 528 historias clínicas elegibles, seincluyeron las de 423 pacientes (el 55,0 % de sexo masculino, mediana de edad 5,3 años). El cuadro clínico fue asintomático en el 31 %, leve en el 39,7 %, moderado en el 23,9 %, grave en el 1,2 %, crítico en el 0,7 %, y el 3,5 % presentó síndrome inflamatorio multisistémico pediátrico (SIMP). Dos pacientes (0,47 %) fallecieron. La prevalencia de CR fue del 10,8 % (intervalo de confianza 95% 8,2-14,2), expresada por leucocituria (16,9 %), proteinuria (16,0 %), hematuria (13,2 %), HTA (3,7 %) y LRA (2,3 %). Ninguno requirió diálisis. Presentar CR se asoció (p <0,0001) con formas graves de enfermedad. Conclusión. La prevalencia de CR en pacientes pediátricos internados con COVID-19 en 13 centros de nuestro país fue del 10,8 % y predominó en las formas clínicas graves.

Introduction. Renal involvement among pediatric patients with coronavirus disease 2019 (COVID-19) ranges between 1.2% and 44%. Given the limited information available locally, the primary objective of this study was to estimate the prevalence of renal involvement in our setting. Population and methods. Cross-sectional study conducted in 13 Argentine sites between March and December 2020. Patients aged 1 month to 18 years hospitalized due to COVID-19 and with at least one measurement of serum creatinine and/or a urinalysis were included. Those with a known kidney disease were excluded. Renal involvement was defined as the presence of acute kidney injury (AKI), proteinuria, hematuria, leukocyturia and/or arterial hypertension (HTN). Results. Among 528 eligible medical records, 423 patients were included (55.0% were males; median age: 5.3 years). The clinical presentation was asymptomatic in 31%; mild, in 39.7%; moderate, in 23.9%; severe, in 1.2%; critical, in 0.7%; and 3.5% had multisystem inflammatory syndrome in children (MIS-C). Two patients (0.47%) died. The prevalence of renal involvement was 10.8% (95% confidence interval: 8.2­14.2); it was described as leukocyturia (16.9%), proteinuria (16.0%), hematuria (13.2%), HTN (3.7%), and AKI (2.3%). No patient required dialysis. Renal involvement was associated with severe forms of disease (p < 0.0001). Conclusion. The prevalence of renal involvement among pediatric patients hospitalized due to COVID-19 in 13 Argentine sites was 10.8%; severe forms of disease prevailed.

Evolución en el corto plazo del compromiso renal en niños con enfermedad por el coronavirus 2019 / Course of renal involvement in the short term in children with coronavirus disease 2019

El compromiso renal en los pacientes pediátricos con enfermedad por el coronavirus 2019 (COVID-19, por su sigla en inglés) varía entre el 10 % y el 80 %. Dado que existe limitada información sobre su pronóstico, se realizó este estudio con el objetivo de describir la evolución en el corto plazo de pacientes a quienes se les detectó compromiso renal durante la internación por COVID-19. Estudio observacional y transversal que incluyó pacientes entre 1 mes y 18 años con COVID-19 con compromiso renal. Se excluyeron aquellos con patología renal conocida. Se identificaron 27 pacientes con afectación renal, en 14 de ellos se pudo realizar seguimiento para estudiar la evolución renal luego de 3 meses del diagnóstico. Todos habían normalizado los niveles de creatinina plasmática durante la internación y al momento del control ambulatorio, realizado a los 145 días (92-193), todos se encontraban normotensos y con hallazgos urinarios normales, excepto uno que persistía con microhematuria. La evolución fue favorable; la mayoría de los pacientes presentaron remisión completa del compromiso renal.

Renal involvement among pediatric patients with coronavirus disease 2019 (COVID-19) ranges between 10 % and 80 %.Given the limited information about its prognosis, the objective of this study was to describe the short-term course of patients in whom renal involvement was detected during hospitalization due to COVID-19. This was an observational, cross-sectional study in patients aged 1 month to 18 years who had COVID-19 and renal involvement. Those with a known kidney disease were excluded. A total of 27 patients with renal involvement were identified; 14 of them were followed-up to study their disease course for 3 months after diagnosis. All of the patients had achieved normal plasma creatinine levels during hospitalization and, at the time of outpatient follow-up, which took place 145 days (92-193) later, all had normal blood pressure and urinary values, except for 1 patient who continued with microscopic hematuria. Course was favorable; in most patients, renal involvement had fully resolved.

Nefropatía por inmunoglobulina M: características histopatológicas y clínicas. Serie de casos / Immunoglobulin M nephropathy: histopathological and clinical characteristics. Case series

La nefropatía por inmunoglobulina M (NIgM) es una glomerulopatía idiopática caracterizada por depósitos mesangiales globales y difusos de IgM. Se realizó un estudio retrospectivo de las características clínicas e histopatológicas de los pacientes con NIgM atendidos en nuestro servicio. De 241 biopsias renales, 21 correspondieron a NIgM (8,7 %). Se incluyeron 18 pacientes (14 de sexo femenino, mediana de edad: 3,08 años). Se excluyó a 1 paciente por enfermedad sistémica asociada y a 2 por seguimiento menor a 1 año. Catorce pacientes se manifestaron con síndrome nefrótico (SN) y 4 con proteinuria aislada o asociada a hematuria. En la microscopia óptica, 13 presentaron hiperplasia mesangial, y 5 esclerosis focal y segmentaria. De los pacientes con SN, 7 fueron corticorresistentes, 4 corticodependientes y 3 presentaban recaídas frecuentes. Todos los pacientes con SN y 1 con proteinuria-hematuria recibieron inmunosupresores; los 18 pacientes recibieron, además, antiproteinúricos. Luego de 5,2 años (2-17,5) de seguimiento, 6 pacientes evolucionaron a enfermedad renal crónica

Immunoglobulin M nephropathy (IgMN) is an idiopathic glomerulopathy characterized by diffuse global mesangial deposits of IgM. We retrospectively studied the clinical and histopathological characteristics of the patients with IgMN seen in our service. Of 241 renal biopsies, 21 corresponded to IgMN (8.7 %). One patient was excluded due to associated systemic disease and 2 due to follow-up less than 1 year, 18 were included (14 girls, median age 3.08 years). Fourteen manifested with nephrotic syndrome (NS) and the remaining with proteinuria (isolated or associated with hematuria). On light microscopy, 13 had hyperplasia with mesangial expansion and 5 had focal and segmental sclerosis. Of the patients with NS, 7 were steroid-resistant, 4 steroid-dependent, and 3 frequent relapsers. All patients with NS and 1 with proteinuria-hematuria received immunosuppressants; the 18 patients also received antiproteinuric drugs. After 5.2 years (2-17.5) of follow-up, 6 patients developed chronic kidney disease.

Sensibilidad diagnóstica de la ampliación de los criterios hematológicos y renales para la definición de síndrome urémico hemolítico / Diagnostic sensitivity of extended renal and hematologic criteria to define hemolytic uremic syndrome

Introducción. La definición habitual de síndrome urémico hemolítico causado por Escherichia coli productora de toxina Shiga (STEC-SUH) se basa en la presencia de anemia, plaquetopenia y elevación de los niveles séricos de creatinina, acompañadas o no de proteinuria y/o hematuria. La definición estricta solo acepta como criterio renal el aumento de la creatinina sérica. La definición amplia mantiene criterios renales flexibles, aunque reemplaza la anemia por hemólisis y acepta la caída brusca del recuento plaquetario como indicador de consumo plaquetario. El objetivo de este estudio fue estimar y comparar la sensibilidad diagnóstica de dichas definiciones en pacientes con STEC-SUH como diagnóstico de egreso hospitalario. Población y métodos. Revisión retrospectiva de las historias clínicas de pacientes con SUH. Se calculó la sensibilidad y el valor predictivo positivo con sus intervalos de confianza 95 % (IC95 %) de las tres definiciones en función del diagnóstico de egreso de STEC-SUH (diagnóstico de referencia). Se utilizó la prueba de McNemar. Resultados. De 208 pacientes, 107 (51,4 %) fueron identificados con la definición estricta, 133 (63,9 %) con la habitual; y 199, con la amplia (95,6 %). La sensibilidad resultó menor para la definición estricta (51,4 %; IC 95 %: 44,8-58,3), intermedia para la habitual (63,9 %; IC 95 %: 56,9-70,4) y mayor para la amplia (95,6 %; IC 95 %: 91,6-97,8); (p < 0,001). Conclusión. Las distintas definiciones de STEC-SUH presentaron diferencias significativas en la sensibilidad diagnóstica. Dado que la definición amplia alcanzó una sensibilidad superior al 95 %, su uso generalizado podría disminuir la demora diagnóstica

Introduction. The usual definition of Shiga toxin-producing Escherichia coli hemolytic uremic syndrome (STEC-HUS) is based on the presence of anemia, thrombocytopenia, and elevated serum creatinine levels, with or without proteinuria and/or hematuria. The strict definition only considers elevated serum creatinine levels as a renal criterion. The extended definition maintains flexible renal criteria, although it replaces anemia with hemolysis and considers a sharp drop in platelet count as an indicator of platelet consumption. The objective of this study was to estimate and compare the diagnostic sensitivity of these definitions in patients with STEC-HUS as hospital discharge diagnosis. Population and methods. Retrospective review of medical records of HUS patients. Sensitivity and positive predictive value, with their corresponding 95 % confidence intervals (CIs), were estimated for the 3 definitions based on a discharge diagnosis of STEC-HUS (reference diagnosis). The McNemar test was used. Results. Out of 208 patients, 107 (51.4 %), 133 (63.9 %), and 199 (95.6 %) were identified with the strict, usual, and extended definition, respectively. Sensitivity was lower for the strict definition (51.4 %; 95 % CI: 44.8-58.3), intermediate for the usual definition (63.9 %; 95 % CI: 56.9-70.4), and higher for the extended one (95.6 %; 95 % CI: 91.6-97.8); (p < 0.001). Conclusion. The different STEC-HUS definitions showed significant differences in diagnostic sensitivity. The extended definition reached a sensitivity above 95 %, so its generalized use may help to reduce diagnostic delays

Constitution and characteristics of the Ibereño herbolarium: a case study within Iberá wetlands (Corrientes, Argentina) / Constitución y características de la herbolaria ibereña: estudio de caso etnobotánico en los humedales del Iberá (Corrientes, Argentina)

This work is based in the investigation about the persistence of the use of medicinal plants in the communities inhabiting the wetlands within Iberá Natural Reserve. From the participant observation and semi-structured interviews, together with the collection of reference plants, the use of 90 medicinal plants to treat 171 ailments, distributed in 12 body systems was recorded. In addition, the informant consensus factor was also calculated and a correspondence analysis was made. It was concluded that the use and knowledge associated to medicinal plants remains active, depending mostly of the native species. For this reason, the maintenance and access to the native flora by ancestral communities is suggested, to conserve the biological and cultural diversity of the Iberá Natural Reserve.

El presente trabajo se basó en la indagación acerca de la persistencia del uso de las plantas medicinales por parte de comunidades que habitan los humedales circunscritos dentro de la Reserva Natural Iberá. A partir de la observación participante y de entrevistas semi- estructuradas, junto a la colecta de los vegetales testigo, se registró el uso de 90 plantas medicinales para tratar 171 afecciones, distribuidas en 12 sistemas corporales. Además, se calculó el indice de uso del consenso de informantes y se realizó un análisis de correspondencias. Se concluyó que el uso y los saberes vinculados a las plantas medicinales se mantienen activos, dependiendo en mayor medida de las especies nativas. Por este motivo, se sugiere mantener el acceso hacia la flora nativa por parte de las comunidades ancestrales con el fin de conservar la diversidad biológica y cultural presentes en la Reserva Natural Iberá.

Diagnóstico de reflujo vesicoureteral según las guías de 1999 y de 2011 del Subcomité de Infección Urinaria de la Academia Americana de Pediatría / Diagnosis of vesicoureteral reflux according to the 1999 and 2011 guidelines of the Subcommittee on Urinary Tract Infection of the American Academy of Pediatrics

Introducción. En 1999, la Academia Americana de Pediatría recomendó realizar una ecografía renal y una cistouretrografía miccional a todos los niños de entre 2 y 24 meses con un primer episodio de infección del tracto urinario (ITU). En 2011, limitó la cistouretrografía miccional a aquellos con ecografía patológica, infecciones recurrentes y/o atípicas. Nuestro objetivo fue comparar, en pacientes con reflujo vesicoureteral (RVU) y ecografía renal normal, la prevalencia de patología relevante según hubieran sido estudiados con las guías de 1999 (en la primera ITU) o de 2011 (ante ITU recurrente y/o atípica). Población y métodos. Estudiamos retrospectivamente pacientes con ITU de entre 2 y 24 meses atendidos entre enero de 2010 y agosto de 2014 con ecografía renal normal y RVU. Consideramos patología relevante al hallazgo de RVU > grado III y/o centellograma renal patológico. Resultados. Incluimos 45 pacientes (31 niñas), que fueron agrupados según hubieran sido estudiados con las guías de 1999 o de 2011. La prevalencia de patología relevante entre los estudiados con las guías de 1999 (9 de 24 casos, 3 con ITU atípica) o de 2011 (11 de 21 casos) fue comparable (37,5% vs. 52%, respectivamente; p= 0,31). Seis pacientes (25%) con patología relevante diagnosticados con las guías de 1999 no se hubieran identificado oportunamente con las de 2011. Conclusiones. La prevalencia de patología relevante identificada en niños con RVU y ecografía renal normal con ambas guías fue comparable. Sin embargo, con las guías actuales, uno de cada cuatro pacientes hubiera estado expuesto a la demora o eventual pérdida diagnóstica si se hubiera esperado la recurrencia para completar la evaluación.

Introduction. In 1999, the American Academy of Pediatrics (AAP) recommended perform a renal ultrasonography and avoiding cystourethrography to all infants between 2 and 24 months of age after their first urinary tract infection (UTI). In 2011, the AAP restricted voiding cystourethrography to children with a pathological ultrasonography, recurrent and/ or atypical infections. Our objective was to compare, in patients with vesicoureteral reflux (VUR) and normal renal ultrasonography, the prevalence of a relevant pathology as if patients had been studied as per the 1999 guidelines (for first UTI) or the 2011 guidelines (for recurrent and/or atypical UTI). Population and methods. We conducted a retrospective analysis of patients with UTI, aged between 2 and 24 months old, seen at our department between January 2010 and August 2014 and who had a normal renal ultrasonography and VUR. A relevant pathology was defined as a finding of grade III VUR or higher and/or pathological renal scintigraphy. Results. Forty-five patients (31 girls) were included and were grouped as if they had been treated as per the 1999 or 2011 guidelines. The prevalence of a relevant pathology among patients studied as per the 1999 guidelines (9 out of 24 cases, 3 with atypical UTI) or as per the 2011 guidelines (11 out of 21 cases) was similar (37.5% versus 52%, respectively; p= 0.31). Six patients (25%) with a relevant pathology diagnosed as per the 1999 guidelines would not have been identified in a timely manner with the 2011 version. Conclusions. The prevalence of a relevant pathology identified in children with VUR and normal renal ultrasonography was similar with both guidelines. However, considering the present guidelines, one out of four patients would have been exposed to a delayed or potentially missed diagnosis if recurrence would have been expected to complete the assessment.

Lúpus eritematoso sistêmico e Anti-Sm / Systemic lupus erythematosus and Anti-sm

Objetivos: Verificar a prevalência de anticorpo anti-Sm na população local com LES e correlacionar sua presença com o perfil clínico e sorológico da doença. Método: Foi realizada uma análise retrospectiva de 350 prontuários dos pacientes com LES. Como critério de inclusão o paciente deveria preencher os critérios classificatórios do ACR e ter a pesquisa do anti-Sm. Foram coletados dados acerca do perfil demográfico, clínico e sorológicos. Resultados: Existia presença do anti-Sm em 22,65%, dos pacientes. Encontrou-se associação significativa do anti-Sm com o anti-RNP. Conclusão: A prevalência do anticorpo anti-Sm foi de 22,65%. Ao correlacionarmos o perfil clínico e sorológico com a presença do anticorpo Anti-Sm, não foi encontrado correlação clínica significativa, havendo apenas relação deste anticorpo com o Anti-RNP

Objectives: To assess the prevalence of anti-Sm in local population with SLE and to determinate its correlation with serological and clinical disease. Metodology: We performed a retrospective analysis of 350 SLE patient's charts. As inclusion criteria the patient should have four of the eleven classification criteria of the ACR and the presence of the test for anti-Sm. We collected demographic, clinical and serological data. Results: Anti-Sm was found in 22.65% of the patients. We found significantly correlation between anti-Sm and anti-RNP. Conclusion: The prevalence of anti-Sm antibodies was 22.65%.No clinical important association was found with this autoantibody except by anti-RNP

Lúpus eritematoso sistêmico e vasculite retiniana / Lupus erythematosus and vasculitis retinal

Descreve-se o caso clinico de uma paciente em tratamento psiquiátrico cujas manifestações oculares levaram ao diagnóstico de lúpus eritematoso sistêmico

A clinical case of a patient in psychiatric treatment whose ocular manifestations led to the diagnosis of systemic lupus erythematosus is described

Associação entre atividade inflamatória e medida de IgA sérica em pacientes com espondiloartrites / Inflammatory activity and the association IgA measure sérum in patients with spondyloarthritis

Objetivo: Verificar se o nível de IgA sérica reflete a atividade inflamatória de pacientes com EAP medido pelo VHS, proteína C reativa e BASDAI ( Bath Ankylosing Spondylitis Disease activity índex) ou com o dano cumulativo da mesma medido pelo BASFI ( Bath Ankylosing Spondylitis Functional Index). Metodologia: Catorze pacientes com EAP foram entrevistados para medida do BASDAI e BASFI e foram submetidos a dosagem de proteína C reativa, VHS e IgA sérica. Resultados: Não se observou correlação entre níveis de Ig A sérica e VHS (p= 0,98), BASDAI (p=0,41) e BASFI (p=0,24 ) uma tendência para associação com proteína C reativa foi observada (p=0,06). Conclusões: Os níveis de Ig A sérica em pacientes com EAP não refletem atividade da doença medida pelo VHS ou pelo BASDAI. UMA tendência é observada com relação a proteína C reativa.

Objective: To verify if the serum IgA level reflects the inflammatory activity of patients with PAD measured by HSV, C-reactive Protein and BASDAI (BathAnkylosing Spondylitis Disease activity index) or with cumulative damage measured by BASFI (Bath Ankylosing Spondylitis Functional Index). Methods: Fourteen patients with PAD were interviewed for BASDAI and BASFI measurements and were submitted to C-reactive protein, VHS and serum IgA. Results: There was no correlation between serum IgA levels and HSV (p = 0.98), BASDAI (p = 0.41) and BASFI (p = 0.24) a trend towards association with C-reactive protein was observed P = 0.06). Conclusions: Serum IgA levels in patients with PAD do not reflect disease activity measured by HSV or BASDAI. A trend is observed with respect to C-reactive protein.

Associação entre massa óssea e estresse oxidativo: análise de marcadores séricos e dados epidemiológicos / Association between bone mass and oxidative stress analysis of serum markers and data epidemiological

Objetivo: Avaliar a relação entre a massa óssea e marcadores séricos de estresse oxidativo/ antioxidação (bilirrubina total/frações e ácido úrico), bem como averiguar a associação entre tais variáveis e outros dados que interferem na massa óssea (idade, alcoolismo, tabagismo, raça, tempo de menopausa e histórico de fraturas). Dosagem de aminotransferases e de enzimas canaliculares foram usadas como marcadores de integridade hepática. Método: Foram selecionados 105 pacientes.A análise do índice de massa óssea foi feita pela verificação dos escores Z, T e g/cm2 (BMD) em fêmur total e coluna vertebral lombar por densitometria pelo método DEXA.Resultados: Foram encontradas correlações entre bilirrubina direta e: T-score (p = 0,0004) e BMD (p=0,0177) de coluna lombar. Também houve correlação entre a bilirrubina total e o T-score de quadril (p= ,0239). Os estudos de correlação entre massa óssea e bilirrubina indireta e com acido úrico não obtiveram resultado significante (p=ns).Conclusão: Existe associação entre bilirrubina total e bilirrubina direta com massa óssea, mostrando que o prejuízo de massa óssea está associado com consumo destes marcadores.

Objective: To evaluate the relation between bone mass and serum markers of oxidative stress/oxidation (total bilirubin / fractions and uric acid), and investigate the association between these variables and other data that interfere with bone (age, alcoholism, smoking, race, time since menopause and history of fractures). aminotransferase dosage and GGT were used as liver integrity markers.Method: About 105 patients were selected. Analysis of bone mass index was made by checking the Z scores, and T g / cm2 (BMD) in total hip and lumbar spine by densitometry by DEXA method.Results: Correlations were found between and direct bilirubin: T-score (p = 0.0004) and BMD (p = 0.0177) in the lumbar spine. There was also a correlation between total bilirubin and hip T-score (p = 0239). The correlation studies between bone mass and indirect bilirubin and uric acid did not obtain significant result (p = ns).Conclusion: There is an association between total bilirubin and direct bilirubin with bone mass, showing that the loss of bone mass is associated with consumption of these markers.

Fatores clínicos, epidemiológicos e histopatológicos associados à instabilidade de microssatélites em câncer colorretal / Factors clinical, epidemiological and histopathological associated with microsatellite instability in colorectal cancer

Objetivo: Verificar a frequência de instabilidade de microssatélites (IMS) em casos de carcinoma colorretal, bem como seus fatores de risco. Material e Método: Foram analisados históricos de pacientes com CCR, avaliando sexo, idade, presença ou ausência de instabilidade de microssatélites MLH-1 e MSH- 2, positividade e negatividade do marcador p53, reatividade do marcador Ki67, profundidade da lesão, invasão vascular e linfonodal e localização do tumor. Resultados: Obteve-se 10,37% de casos com IMS. Não houve correlação entre IMS e idade, gênero, localização do tumor, invasão linfonodal e vascular, profundidade da lesão, mutação de TP53 e taxa de proliferação por anti Ki67. Conclusão: Nesse estudo a presença de IMS no CCR não apresentou relação com fatores clínicos e epidemiológicos conhecidos para essa neoplasia.

Objective: The aim of this study was to verify the frequency of microsatellite instability (MSI) in cases of colorectal carcinoma and their risk factors. Material and Method: We analyzed historical CRC patients, evaluating sex, age, instability MLH -1 microsatellite and MSH- 2 , positivity of the p53 marker, percentage of Ki67 marker , presence of lymph nodes metastases , depth of lesion , vascular and lymph nodes invasion and tumor location. Results: There was 10.37 % of cases with IMS. There was no correlation between IMS and age, gender, tumor location , lymph node and vascular invasion, depth of the lesion , TP53 mutation and proliferation rate by anti Ki67. Conclusion: The presence of IMS in CRC is not related with clinical and epidemiological factors known to this neoplasm.

Aneurisma bilateral de carótidas em paciente com lupus eritematoso sistêmico / Aneurysm carotid of bilateral in patient with systemic lupus erythematosus

Descreve-se um caso de lúpus eritematoso sistêmico (LES) complicado com vasculite de SNC. Na investigação desta última encontraram-se aneurismas de carótida comum e interna bilateralmente - os quais foram tratados cirurgicamente após imunossupressão.

A case of systemic lupus erythematosus (SLE) complicated by CNS vasculitis is described. In the investigation of the latter we found common and internal carotid aneurysms bilaterally - which were treated surgically after immunosuppression.

Artropatia por hemocromatose / Hemochromatosis arthropathy

A hemocromatose pode se manifestar como osteoartrite de inicio precoce e que afeta, de maneira atipica, as articulações metacarpofalangianas. Seu reconhecimento pode permitir o diagnóstico precoce e tratamento de uma doença potencialmente fatal. Descrevem-se aqui dois casos de hemocromatose com manifestações articulares.

Hemochromatosis can manifest as early-onset osteoarthritis and affects, in atypical way, the metacarpophalangeal joints. Its recognition may allow a nearly diagnosis and treatment of a potentially fatal disease. Here, two patients with hemochromatosis and articular manifestations are described.

Hipercalciuria idiopática en niños con infección del tracto urinario / Idiopathic hypercalciuria in children with urinary tract infection

Introducción. La hipercalciuria idiopática (HI) predispone al desarrollo de infección del tracto urinario (ITU); sin embargo, hay escasa información local sobre dicha asociación. Nuestros objetivos fueron estimar la prevalencia de HI en niños con ITU y evaluar si esta difería según la presencia o no de reflujo vesicoureteral (RVU). Complementariamente, analizamos la asociación entre HI y la ingesta de sal. Población y métodos. Determinamos la calciuria a pacientes menores de 18 años con ITU estudiada (ecografía y cistouretrografía miccional) y ausencia de causas secundarias de hipercalciuria. Consideramos HI al cociente calcio/creatinina > 0,8; 0,6; 0,5 y 0,2 en niños de 0-6 meses, 7-12 meses, 12-24 meses y en los mayores de 2 años, respectivamente; e ingesta elevada de sodio, al cociente sodio/potasio urinario > 2,5. Resultados. En 136 pacientes (87 niñas, mediana de edad 3 años), la prevalencia de HI fue de 20%. Los pacientes con (n= 54) y sin (n= 82) RVU fueron similares en género, peso, talla, edad al diagnóstico y al momento del estudio, características clínicas (hematuria, nefrolitiasis, dolor cólico y recurrencia de ITU), antecedentes familiares de nefrolitiasis y en la prevalencia de HI (26% vs. 16%, p= 0,24). Los niños hipercalciúricos presentaron ingesta elevada de sodio más frecuentemente que los normocalciúricos (76% vs. 46%, p= 0,007). Conclusiones. La prevalencia de HI en niños con ITU fue alta (20%) y no difirió entre los pacientes con y sin RVU. Sería recomendable la búsqueda de HI en los niños con ITU, independientemente de la presencia o no de RVU.

Introduction. Idiopathic hypercalciuria (IH) predisposes to urinary tract infections (UTIs); however, there is scarce local information regarding such association. Our objectives were to estimate IH prevalence in children with UTI and to assess whether there were differences in relation to the presence or absence of vesicoureteral reflux (VUR). Additionally, the association between IH and salt intake was studied. Population and Methods. Calciuria was determined in patients younger than 18 years old on whom UTI had been studied (ultrasound and voiding cystourethrogram), and who had no secondary causes of hypercalciuria. IH was defined as a calcium to creatinine ratio of >0.8, 0.6, 0.5 and 0.2 in children aged 0 to 6 months old, 7 to12 months old, 12 to 24 months old and older than 2 years old, respectively; and a high sodium intake with a urinary sodium to potassium ratio of >2.5. Results. IH prevalence among 136 patients (87 girls, median age: 3 years old) was 20%. Patients with VUR (n= 54) and without VUR (n= 82) had similar characteristics in terms of sex, weight, height, age at diagnosis and age at the time of the study, and clinical features (hematuria, nephrolithiasis, colicky pain, and recurrent UTI), family history of kidney stone formation, and IH prevalence (26% versus 16%, p= 0.24). A high sodium intake was more frequently observed in children with hypercalciuria than in those with normal urine calcium levels (76% versus 46%, p= 0.007). Conclusions. IH prevalence in children with UTI was high (20%), with no differences observed between patients with and without VUR. As a recommendation, the presence of IH should be detected in children with UTI, regardless of VUR presence or absence.

Acute kidney injury in critically ill children: incidence and risk factors for mortality / Daño renal agudo en niños críticos: incidencia y factores de riesgo de mortalidad

Introduction. Acute kidney injury is a common complication associated with an increase in mortality in children who require intensive care. The objective of this study was to determine the incidence of acute kidney injury and identify risk factors for mortality in critically ill patients hospitalized in our facility. Patients and Methods. This was a prospective and observational study conducted at the Intensive Care Unit (ICU) of Hospital Pedro de Elizalde between 2005 and 2009. All patients with acute kidney injury were included, and those with chronic renal failure, prerenal acute kidney injury, hepatorenal syndrome, newborn infants, and postoperative cardiovascular surgery patients were excluded. The sample was divided into survivors and deceased patients so as to identify risk factors for mortality using univariate and multivariate analyses, taking their clinical characteristics as predictive variable, and death at the ICU as the outcome variable. Results. Out of 1496 patients, 66 developed acute kidney injury (4.4%). The cause was secondary in 72.8% of cases, and due to primary kidney disease in 27.2% of cases. Mortality rate was 44% (29 patients). The univariate analysis showed that the presence of anuria (p= 0.0003; OR: 7.01; 95% CI: 2.3-21.35) and the need of dialysis (p= 0.0009; OR: 6.35; 95% CI: 2.03-9.88) were signifcantly higher in deceased patients. The multiple regression analysis identifed that the need of dialysis (p = 0.0002; OR: 5.94; 95% CI: 1.85-19.04) was an independent risk factor for mortality. Conclusions. The incidence of acute kidney injury in critically ill children was 4.4%, and the need of dialysis was an independent predictor of mortality.

Introducción. El daño renal agudo es una complicación frecuente que se asocia a un aumento de la mortalidad en los niños que requieren cuidados intensivos. El objetivo de este estudio fue determinar su incidencia e identifcar los factores de riesgo de mortalidad en los pacientes críticos internados en nuestra institución. Pacientes y métodos. Estudio prospectivo y observacional realizado en la unidad de terapia intensiva (UTI) del Hospital Pedro de Elizalde entre 2005 y 2009. Se incluyeron todos los pacientes con daño renal agudo, exceptuando a aquellos con insufciencia renal crónica, daño agudo prerrenal, síndrome hepatorrenal, recién nacidos y posquirúrgicos cardiovasculares. La muestra se dividió en sobrevivientes y fallecidos para identifcar los factores de riesgo de mortalidad mediante un análisis univariado y multivariado, considerando como variable de predicción sus características clínicas, y de resultado, la muerte en la UTI. Resultados. De 1496 pacientes, 66 presentaron daño renal agudo (4,4%). En el 72,8% de los casos fue de causa secundaria y en el 27,2%, por enfermedad renal primaria. La mortalidad fue de 44% (29 pacientes). En el análisis univariado la presencia de anuria (p= 0,0003; OR 7,01; IC 95% 2,3 a 21,35) y la necesidad de diálisis (p= 0,0009; OR 6,35; IC 95% 2,03 a 9,88) fueron signifcativamente mayores en los fallecidos. Por regresión múltiple se identifcó la necesidad de diálisis (p= 0,0002; OR 5,94; IC 95% 1,85 a 19,04) como factor de riesgo independiente de mortalidad. Conclusiones. La incidencia de daño renal agudo en los niños críticos fue de 4,4% y el requerimiento de diálisis fue un predictor independiente de mortalidad.

Capacidad del período oligoanúrico para predecir secuela renal en niños con síndrome urémico-hemolítico asociado a diarrea / Capacity of the oligoanuric period in the prediction of renal sequelae in patients with postdiarrheal hemolytic uremic syndrome

Introducción. La duración del período oligoanúrico es el principal marcador pronóstico de secuela renal en pacientes con síndrome urémico-hemolítico asociado a diarrea (SUH D+). Realizamos este estudio con el objetivo de determinar la capacidad del período oligoanúrico para predecir secuela renal en niños con SUH D+. Pacientes y métodos. Revisamos los datos de todos los pacientes internados en el Hospital Elizalde con SUH D+ entre 1998-2008 e incluimos sólo a aquellos seguidos más de 1 año. Consideramos secuela renal a la presencia de albuminuria y/o proteinuria patológicas y/o hipertensión arterial y/o caída de fltrado glomerular. Ingresaron al estudio 80 pacientes, que se dividieron en 2 grupos (con secuela y sin ella). Se determinó si tenían diferencias en la duración del período oligoanúrico y se calculó la capacidad de dicha variable para predecir secuela mediante curva ROC. Resultados. 32 pacientes presentaron secuela renal (prevalencia 40%), quienes tuvieron un período oligoanúrico signifcativamente más prolongado [mediana 7 días (intervalo 0-14) contra mediana 0 días (intervalo 0-30); p= 0,0003] que aquellos sin secuela. Mediante curva ROC (área bajo la curva de 0,73) se estableció en ≥ 4 días como mejor punto de corte del período oligoanúrico para predecir secuela renal (sensibilidad 68,75%, especifcidad 70,83%). Conclusión. La curva ROC no permitió identifcar un punto de corte de la duración del período oligoanúrico que permita predecir secuela renal con sensibilidad y especifcidad adecuadas. Esta observación refuerza la importancia del seguimiento periódico y a largo plazo de todos los niños afectados por SUH D+.

Introduction. Length of the oligoanuric period is the main predictor of renal sequelae in children with postdiarrehal hemolytic uremic syndrome (D+ HUS). We aimed to determine the capacity of the oligoanuric period in the prediction of renal sequelae in children with D+ HUS. Patients and methods. We reviewed data from all patients with D+ HUS admitted at Hospital Elizalde between 1998-2008, including only those with at least 1 year of follow-up. Renal sequelae were defned by the presence of pathologic albuminuria and/or proteinuria and/or arterial hypertension and/or chronic renal failure; 80 patients were included, belonging to one of two groups (with or without sequelae). Difference in the duration of the oligoanuric period between groups was determined, and the diagnostic capacity of the oligoanuric period to identifed renal sequelae was assessed by ROC curve. Results. 32 patients presented sequelae, representing a prevalence of 40%. Oligoanuric period was signifcantly longer in patients with sequelae [median 7 days (range 0-14) vs median 0 days (range 0-30); p= 0,0003]. Using ROC curve (aucROC= 0.73) we identifed an oligoanuric period ≥ 4 days as the best threshold to predict renal sequelae (sensitivity 68.75%, and specifcity 70.83%). Conclusions. By ROC curve analysis we were unable to identify a cut-off point on the length of the oligoanuric period which predicts renal sequelae with optimum sensitivity and specifcity. This observation emphasizes the need of periodic and long-term surveillance of all children who suffered from D+ HUS.

Síndrome de hipomagnesemia familiar con hipercalciuria y nefrocalcinosis: presentación de un caso / Familial hypomagnesemia, hypercalciuria with nephrocalcinosis syndrome: report of a case

El síndrome de hipomagnesemia familiar con hipercalciuria y nefrocalcinosis (OMIM 248250) es una enfermedad autosómica recesiva infrecuente, que se caracteriza por la pérdida renal decalcio y magnesio, evoluciona a la disminución progresiva de la función renal y, finalmente, requiere trasplante.Los hallazgos clínicos incluyen, entre otros, infección urinaria a repetición, poliuria, polidipsia, calambres, temblores, convulsiones; asociados a trastornos oculares y auditivos.Se presenta una paciente de 4 años de edad, con clínica, exámenescomplementarios y antecedentes personales y familiares compatibles con este síndrome. Su forma de presentaciónfue de signos y síntomas habituales en la práctica diaria (fiebre, dolor abdominal, poliuria y polidipsia) que podrían diferir su diagnóstico.